doi:10.1007/s12250-018-0031-4

Alberts AS, Montminy M, Shenolikar S, Feramisco JR, 1994: Expression of a peptide inhibitor of protein phosphatase 1 increases phosphorylation and activity of CREB in NIH 3T3 fibroblasts[J]. Mol Cell Biol, 14, 4398-4407. doi: 10.1128/MCB.14.7.4398
Ali A, Banerjea AC, 2016: Curcumin inhibits HIV-1 by promoting Tat protein degradation[J]. Sci Rep, 6, 27539-. doi: 10.1038/srep27539
Avdoshina V, Garzino-Demo A, Bachis A, Monaco MC, Maki PM, Tractenberg RE, Liu C, Young MA, Mocchetti I, 2011: HIV-1 decreases the levels of neurotrophins in human lymphocytes[J]. AIDS, 25, 1126-1128. doi: 10.1097/QAD.0b013e32834671b3
Bachis A, Avdoshina V, Zecca L, Parsadanian M, Mocchetti I, 2012: Human immunodeficiency virus type 1 alters brain-derived neurotrophic factor processing in neurons[J]. J Neurosci, 32, 9477-9484. doi: 10.1523/JNEUROSCI.0865-12.2012
Benito E, Barco A, 2010: CREB's control of intrinsic and synaptic plasticity: implications for CREB-dependent memory models[J]. Trends Neurosci, 33, 230-240. doi: 10.1016/j.tins.2010.02.001
Bennett MR, Lagopoulos J, 2014: Stress and trauma: BDNF control of dendritic-spine formation and regression[J]. Prog Neurobiol, 112, 80-99. doi: 10.1016/j.pneurobio.2013.10.005
Bertrand SJ, Aksenova MV, Mactutus CF, Booze RM, 2013: HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury[J]. Exp Neurol, 248, 228-235. doi: 10.1016/j.expneurol.2013.06.020
Bordelon JR, Smith Y, Nairn AC, Colbran RJ, Greengard P, Muly EC, 2005: Differential localization of protein phosphatase-1alpha, beta and gamma1 isoforms in primate prefrontal cortex[J]. Cereb Cortex, 15, 1928-1937. doi: 10.1093/cercor/bhi070
Chang JR, Mukerjee R, Bagashev A, Del Valle L, Chabrashvili T, Hawkins BJ, He JJ, Sawaya BE, 2011: HIV-1 Tat protein promotes neuronal dysfunction through disruption of microRNAs[J]. J Biol Chem, 286, 41125-41134. doi: 10.1074/jbc.M111.268466
Deyer SM, Rodriguez M, Lapierre J, Costinl BN, El-Hage N, 2015: Differing roles of autophagy in HIV-associated neurocognitive impairment and encephalitis with implications for morphine coexposure[J]. Front Microbiol, 6, 653-.
Dohadwala M, da Cruz e Silva EF, Hall FL, Williams RT, CarbonaroHall DA, Nairn AC, Greengard P, Berndt N, 1994: Phosphorylation and inactivation of protein phosphatase 1 by cyclindependent kinases[J]. Proc Natl Acad Sci USA, 91, 6408-6412. doi: 10.1073/pnas.91.14.6408
Dore K, Aow J, Malinow R, 2015: Agonist binding to the NMDA receptor drives movement of its cytoplasmic domain without ion flow[J]. Proc Natl Acad Sci USA, 112, 14705-14710. doi: 10.1073/pnas.1520023112
Eggers C, Arendt G, Hahn K, Husstedt IW, Maschke M, Neuen-Jacob E, Obermann M, Rosenkranz T, Schielke E, Straube E, 2017: HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment[J]. J Neurol, 264, 1715-1727. doi: 10.1007/s00415-017-8503-2
Ellis R, Langford D, Masliah E, 2007: HIV and antiretroviral therapy in the brain: neuronal injury and repair[J]. Nat Rev Neurosci, 8, 33-44. doi: 10.1038/nrn2040
Eugenin EA, D'Aversa TG, Lopez L, Calderon TM, Berman JW, 2003: MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis[J]. J Neurochem, 85, 1299-1311. doi: 10.1046/j.1471-4159.2003.01775.x
Eugenin EA, King JE, Nath A, Calderon TM, Zukin RS, Bennett MV, Berman JW, 2007: HIV-tat induces formation of an LRP-PSD- 95-NMDAR-nNOS complex that promotes apoptosis in neurons and astrocytes[J]. Proc Natl Acad Sci USA, 104, 3438-3443. doi: 10.1073/pnas.0611699104
Fitting S, Xu R, Bull C, Buch SK, El-Hage N, Nath A, Knapp PE, Hauser KF, 2010: Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons[J]. Am J Pathol, 177, 1397-1410. doi: 10.2353/ajpath.2010.090945
Fitting S, Ignatowska-Jankowska BM, Bull C, Skoff RP, Lichtman AH, Wise LE, Fox MA, Su J, Medina AE, Krahe TE, Knapp PE, Guido W, Hauser KF, 2013: Synaptic dysfunction in the hippocampus accompanies learning and memory deficits in human immunodeficiency virus type-1 Tat transgenic mice[J]. Biol Psychiatry, 73, 443-453. doi: 10.1016/j.biopsych.2012.09.026
Garden GA, Budd SL, Tsai E, Hanson L, Kaul M, D'Emilia DM, Friedlander RM, Yuan JY, Masliah E, Lipton SA, 2002: Caspase cascades in human immunodeficiency virus-associated neurodegeneration[J]. J Neurosci, 22, 4015-4024. doi: 10.1523/JNEUROSCI.22-10-04015.2002
Genoux D, Haditsch U, Knobloch M, Michalon A, Storm D, Mansuy IM, 2002: Protein phosphatase 1 is a molecular constraint on learning and memory[J]. Nature, 418, 970-975. doi: 10.1038/nature00928
Green M, Loewenstein PM, 1988: Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein[J]. Cell, 55, 1179-1188. doi: 10.1016/0092-8674(88)90262-0
Hou H, Sun L, Siddoway BA, Petralia RS, Yang H, Gu H, Nairn AC, Xia H, 2013: Synaptic NMDA receptor stimulation activates PP1 by inhibiting its phosphorylation by Cdk5[J]. J Cell Biol, 203, 521-535. doi: 10.1083/jcb.201303035
Hu XD, Huang Q, Yang X, Xia H, 2007: Differential regulation of AMPA receptor trafficking by neurabin-targeted synaptic protein phosphatase-1 in synaptic transmission and long-term depression in hippocampus[J]. J Neurosci, 27, 4674-4686. doi: 10.1523/JNEUROSCI.5365-06.2007
Kim HJ, Martemyanov KA, Thayer SA, 2008: Human immunodeficiency virus protein Tat induces synapse loss via a reversible process that is distinct from cell death[J]. J Neurosci, 28, 12604-12613. doi: 10.1523/JNEUROSCI.2958-08.2008
Koleske AJ, 2013: Molecular mechanisms of dendrite stability[J]. Nat Rev Neurosci, 14, 536-550. doi: 10.1038/nrn3486
Kwon YG, Lee SY, Choi Y, Greengard P, Nairn AC, 1997: Cell cycle-dependent phosphorylation of mammalian protein phosphatase 1 by cdc2 kinase[J]. Proc Natl Acad Sci USA, 94, 2168-2173. doi: 10.1073/pnas.94.6.2168
Li W, Huang Y, Reid R, Steiner J, Malpica-Llanos T, Darden TA, Shankar SK, Mahadevan A, Satishchandra P, Nath A, 2008: NMDA receptor activation by HIV-Tat protein is clade dependent[J]. J Neurosci, 28, 12190-12198. doi: 10.1523/JNEUROSCI.3019-08.2008
Lu SM, Tremblay ME, King IL, Qi J, Reynolds HM, Marker DF, Varrone JJ, Majewska AK, Dewhurst S, Gelbard HA, 2011: HIV-1 Tat-induced microgliosis and synaptic damage via interactions between peripheral and central myeloid cells[J]. PLoS ONE, 6, e23915-. doi: 10.1371/journal.pone.0023915
Lu B, Nagappan G, Guan X, Nathan PJ, Wren P, 2013: BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases[J]. Nat Rev Neurosci, 14, 401-416. doi: 10.1038/nrn3505
Ma M, Nath A, 1997: Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells[J]. J Virol, 71, 2495-2499.
Maragos WF, Tillman P, Jones M, Bruce-Keller AJ, Roth S, Bell JE, Nath A, 2003: Neuronal injury in hippocampus with human immunodeficiency virus transactivating protein, Tat[J]. Neuroscience, 117, 43-53. doi: 10.1016/S0306-4522(02)00713-3
Martinez-Cerdeno V, 2017: Dendrite and spine modifications in autism and related neurodevelopmental disorders in patients and animal models[J]. Dev Neurobiol, 77, 393-404. doi: 10.1002/dneu.v77.4
Munton RP, Vizi S, Mansuy IM, 2004: The role of protein phosphatase-1 in the modulation of synaptic and structural plasticity[J]. FEBS Lett, 567, 121-128. doi: 10.1016/j.febslet.2004.03.121
Nath A, Psooy K, Martin C, Knudsen B, Magnuson DS, Haughey N, Geiger JD, 1996: Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic[J]. J Virol, 70, 1475-1480.
Nath S, Bachani M, Harshavardhana D, Steiner JP, 2012: Catechins protect neurons against mitochondrial toxins and HIV proteins via activation of the BDNF pathway[J]. J Neurovirol, 18, 445-455. doi: 10.1007/s13365-012-0122-1
Park H, Poo MM, 2013: Neurotrophin regulation of neural circuit development and function[J]. Nat Rev Neurosci, 14, 7-23.
Rao VR, Ruiz AP, Prasad VR, 2014: Viral and cellular factors underlying neuropathogenesis in HIV associated neurocognitive disorders (HAND)[J]. AIDS Res Ther, 11, 13-. doi: 10.1186/1742-6405-11-13
Rebelo S, Santos M, Martins F, da Cruz e Silva EF, da Cruz e Silva OA, 2015: Protein phosphatase 1 is a key player in nuclear events[J]. Cell Signal, 27, 2589-2598. doi: 10.1016/j.cellsig.2015.08.007
Rex CS, Lin CY, Kramar EA, Chen LY, Gall CM, Lynch G, 2007: Brain-derived neurotrophic factor promotes long-term potentiation-related cytoskeletal changes in adult hippocampus[J]. J Neurosci, 27, 3017-3029. doi: 10.1523/JNEUROSCI.4037-06.2007
Robertson K, Bayon C, Molina JM, McNamara P, Resch C, MunozMoreno JA, Kulasegaram R, Schewe K, Burgos-Ramirez A, De Alvaro C, Cabrero E, Guion M, Norton M, van Wyk J, 2014: Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada[J]. AIDS Care, 26, 1555-1561. doi: 10.1080/09540121.2014.936813
Sacktor N, Skolasky RL, Seaberg E, Munro C, Becker JT, Martin E, Ragin A, Levine A, Miller E, 2016: Prevalence of HIVassociated neurocognitive disorders in the multicenter AIDS cohort study[J]. Neurology, 86, 334-340. doi: 10.1212/WNL.0000000000002277
Sagnier S, Daussy CF, Borel S, Robert-Hebmann V, Faure M, Blanchet FP, Beaumelle B, Biard-Piechaczyk M, Espert L, 2015: Autophagy restricts HIV-1 infection by selectively degrading Tat in CD4+T lymphocytes[J]. J Virol, 89, 615-625. doi: 10.1128/JVI.02174-14
Sakamoto K, Karelina K, Obrietan K, 2011: CREB: a multifaceted regulator of neuronal plasticity and protection[J]. J Neurochem, 116, 1-9. doi: 10.1111/jnc.2010.116.issue-1
Shi Y, 2009: Serine/threonine phosphatases: mechanism through structure[J]. Cell, 139, 468-484. doi: 10.1016/j.cell.2009.10.006
Shin AH, Thayer SA, 2013: Human immunodeficiency virus-1 protein Tat induces excitotoxic loss of presynaptic terminals in hippocampal cultures[J]. Mol Cell Neurosci, 54, 22-29. doi: 10.1016/j.mcn.2012.12.005
Strack S, Barban MA, Wadzinski BE, Colbran RJ, 1997: Differential inactivation of postsynaptic density-associated and soluble Ca²⁺/calmodulin-dependent protein kinase Ⅱ by protein phosphatases 1 and 2A[J]. J Neurochem, 68, 2119-2128.
Tao X, Finkbeiner S, Arnold DB, Shaywitz AJ, Greenberg ME, 1998: Ca²⁺ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism[J]. Neuron, 20, 709-726. doi: 10.1016/S0896-6273(00)81010-7
Wayman WN, Chen L, Napier TC, Hu XT, 2015: Cocaine selfadministration enhances excitatory responses of pyramidal neurons in the rat medial prefrontal cortex to human immunodeficiency virus-1 Tat[J]. Eur J Neurosci, 41, 1195-1206. doi: 10.1111/ejn.2015.41.issue-9
Xiao H, Neuveut C, Tiffany HL, Benkirane M, Rich EA, Murphy PM, Jeang KT, 2000: Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1[J]. Proc Natl Acad Sci USA, 97, 11466-11471. doi: 10.1073/pnas.97.21.11466
Yang H, Hou H, Pahng A, Gu H, Nairn AC, Tang YP, Colombo PJ, Xia H, 2015: Protein phosphatase-1 inhibitor-2 Is a novel memory suppressor[J]. J Neurosci, 35, 15082-15087. doi: 10.1523/JNEUROSCI.1865-15.2015
Zhong Y, Zhang B, Eum SY, Toborek M, 2012: HIV-1 Tat triggers nuclear localization of ZO-1 via Rho signaling and cAMP response element-binding protein activation[J]. J Neurosci, 32, 143-150. doi: 10.1523/JNEUROSCI.4266-11.2012
Zhou HX, Li XY, Li FY, Liu C, Liang ZP, Liu S, Zhang B, Wang TY, Chu TC, Lu L, Ning GZ, Kong XH, Feng SQ, 2014: Targeting RPTPsigma with lentiviral shRNA promotes neurites outgrowth of cortical neurons and improves functional recovery in a rat spinal cord contusion model[J]. Brain Res, 1586, 46-63. doi: 10.1016/j.brainres.2014.08.048
Zhu J, Midde NM, Gomez AM, Sun WL, Harrod SB, 2015: Intraventral tegmental area HIV-1 Tat_1-86 attenuates nicotine-mediated locomotor sensitization and alters mesocorticolimbic ERK and CREB signaling in rats[J]. Front Microbiol, 6, 540-.